Gianluca Franceschini: The Difference in Breast Cancer is Made by the Team
Gianluca Franceschini, Director of the Research and Training Center on Integrated Therapies in Breast Neoplasms, Full Professor of General Surgery and Director of the Master’s Program in Integrated Therapies for Female Oncological Pathologies at Catholic University of the Sacred Heart, shared a post on LinkedIn:
“The difference, in breast cancer, is made by the Team!
I had the pleasure of participating in the program ‘Il Confronto‘ on Rai 2, conducted by Monica Setta, in an episode dedicated to current health, economic and social issues together with Lando Maria Sileoni (Secretary General of the Autonomous Federation of Italian Banks), Dario Lo Bosco (General Manager of Italferr) and Corrado Chiominto (Editor-in-Chief of the economic and financial editorial staff of the Ansa Agency).
During my speech, I wanted to draw attention to a fundamental issue for women’s health: the importance of being treated within a Breast Unit.
The scientific evidence is now very clear: women treated in multidisciplinary centers dedicated to breast cancer have greater survival and better quality of life.
The real difference today is not the individual doctor, but the strength of the team!
Continuing to inform and raise awareness on this issue is essential, because the quality of the organization of care can make a difference in people’s lives.
Here is the video with the full interview.”
Proceed to the video attached to the post.
Other posts featuring Gianluca Franceschini on Hemostasis Today.
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls
-
Apr 14, 2026, 16:49Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS